Entasis Therapeutics Holdings Inc. — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2021)

-$47.1M

Total Assets (FY2021)

$40.9M

Total Equity (FY2021)

$31.2M

Cash Flows from Operating Activities (FY2021)

-$43.0M

Source: Entasis Therapeutics Holdings Inc. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.